CoreCap Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History

CoreCap Advisors’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.47K	Hold	5	–	–	﹤0.01%	2617
2026 Q1	$1.39K	Hold	5	–	–	﹤0.01%	2477
2025 Q4	$1.51K	Buy	+5	New	+$1.56K	﹤0.01%	2528
2024 Q2	–	Sell	-122	Closed	-$42.2K	–	1715
2024 Q1	$42.2K	Buy	+122	New	+$40.1K	﹤0.01%	1180
2022 Q3	–	Sell	-193	Closed	-$96K	–	697
2022 Q2	$96K	Buy	+193	New	+$101K	0.01%	704

Other funds holding BIO

Assenagon Asset Management

Assenagon Asset Management Senningerberg, Luxembourg $77B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

Beacon Investment Advisory Services Morristown, New Jersey $2.69B AUM 35.07% 1-Year Est. Return

Financial Management Professionals Austin, Texas $1.05B AUM 21.07% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Wolff Wiese Magana Carslbad, California $217M AUM 47.64% 1-Year Est. Return